|
March 27, 2006 Categories: Uncategorized Posted by admin
Medtronic, Inc. today announced that it has received U.S. Food and Drug Administration approval of the AneuRx® AAAdvantage™ abdominal aortic aneurysm (AAA) stent graft with Xcelerant® delivery system. AneuRx AAAdvantage is a next-generation, minimally-invasive device that treats dangerous bulges in the aorta, the body’s largest artery, that can rupture without warning.
Full press release
|
|
